caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1720058381

Jesse Helton

PRACTICEMODERN UROLOGY, INC.See all providers at this practice →
Internal MedicineFestus, MOI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Jesse Helton's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CRYSTAL OAKS LONG TERM CARE28114
MERCY HOSPITALS EAST COMMUNITIES2362
Jason Kayser
Diagnostic Radiology · Saint Louis, MO
2153
Keith Kastelic
Diagnostic Radiology · Leesburg, FL
1731
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Maryland Heights, MO
1343
Jung Lee
Cardiology · Crystal City, MO
1246
Robert Evens
Emergency Medicine · Crystal City, MO
1227
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
15
Beneficiaries
—
Total drug cost
$649
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Desmopressin Acetate15 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.